Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for abbott in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (126)
Results: 1-50 | Export
  1. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Luz Herrera, General Manager - Canada, Abbott Diabetes Care
    Registration: 26 of 26 (2024-02-08 to present)
    Posted: 2024-03-11
    Subject matter details: 4
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  2. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: RAMI FAYED, Vice President and General Manager, Canada
    Registration: 38 of 39 (2024-02-01 to 2024-02-01)
    Posted: 2024-02-27
    Subject matter details: 17
    Government institutions: 24
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 18
  3. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: RAMI FAYED, Vice President and General Manager, Canada
    Registration: 39 of 39 (2024-02-01 to present)
    Posted: 2024-02-28
    Subject matter details: 17
    Government institutions: 24
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 17
  4. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 37 of 39 (2024-01-08 to 2024-02-01)
    Posted: 2024-01-25
    Subject matter details: 17
    Government institutions: 24
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 18
  5. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 36 of 39 (2023-12-21 to 2024-01-08)
    Posted: 2023-12-22
    Subject matter details: 17
    Government institutions: 24
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 19
  6. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 35 of 39 (2023-12-08 to 2023-12-21)
    Posted: 2023-12-11
    Subject matter details: 9
    Government institutions: 24
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 15
  7. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Luz Herrera, General Manager - Canada, Abbott Diabetes Care
    Registration: 25 of 26 (2023-11-20 to 2024-02-08)
    Posted: 2023-12-13
    Subject matter details: 4
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  8. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 34 of 39 (2023-11-01 to 2023-12-08)
    Posted: 2023-11-29
    Subject matter details: 8
    Government institutions: 23
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  9. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 33 of 39 (2023-10-05 to 2023-11-01)
    Posted: 2023-10-06
    Subject matter details: 8
    Government institutions: 21
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  10. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Luz Herrera, General Manager - Canada, Abbott Diabetes Care
    Registration: 24 of 26 (2023-09-20 to 2023-11-20)
    Posted: 2023-10-03
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  11. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Luz Herrera, General Manager - Canada, Abbott Diabetes Care
    Registration: 23 of 26 (2023-06-09 to 2023-09-20)
    Posted: 2023-07-11
    Subject matter details: 3
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  12. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Maria Karounis, General Manager - Canada, Abbott Nutrition
    Registration: 22 of 26 (2023-03-27 to 2023-06-09)
    Posted: 2023-04-05
    Subject matter details: 3
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  13. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Philippe Busque, General Manager - Canada, Abbott Diabetes Care
    Registration: 21 of 26 (2023-02-03 to 2023-03-27)
    Posted: 2023-03-02
    Subject matter details: 3
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  14. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 31 of 39 (2022-12-14 to 2022-12-14)
    Posted: 2022-12-22
    Subject matter details: 8
    Government institutions: 20
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  15. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 32 of 39 (2022-12-14 to 2023-10-05)
    Posted: 2022-12-23
    Subject matter details: 8
    Government institutions: 21
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  16. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Philippe Busque, General Manager - Canada, Abbott Diabetes Care
    Registration: 20 of 26 (2022-11-24 to 2023-02-03)
    Posted: 2022-12-02
    Subject matter details: 3
    Government institutions: 8
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  17. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Philippe Busque, General Manager - Canada, Abbott Diabetes Care
    Registration: 19 of 26 (2022-09-20 to 2022-11-24)
    Posted: 2022-10-04
    Subject matter details: 3
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  18. Abbott Laboratories
    Type: Consultant
    Lobbyist: Michael Agosti, Dentons Canada LLP
    Registration: 3 of 3 (2022-09-01 to present)
    Posted: 2022-09-20
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  19. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Philippe Busque, General Manager - Canada, Abbott Diabetes Care
    Registration: 18 of 26 (2022-06-20 to 2022-09-20)
    Posted: 2022-06-23
    Subject matter details: 3
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 2
  20. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 30 of 39 (2022-06-01 to 2022-12-14)
    Posted: 2022-06-20
    Subject matter details: 8
    Government institutions: 20
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  21. Abbott Laboratories Co.
    Type: Consultant
    Lobbyist: Keith McIntosh, GLOBAL PUBLIC AFFAIRS INC.
    Registration: 1 of 1 (2022-03-14 to 2022-06-01)
    Posted: 2022-03-23
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  22. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 17 of 26 (2022-03-01 to 2022-06-20)
    Posted: 2022-04-06
    Subject matter details: 3
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  23. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 15 of 26 (2022-02-18 to 2022-02-18)
    Posted: 2022-02-28
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  24. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 16 of 26 (2022-02-18 to 2022-03-01)
    Posted: 2022-03-02
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  25. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 29 of 39 (2022-02-07 to 2022-06-01)
    Posted: 2022-02-23
    Subject matter details: 8
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 12
  26. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 14 of 26 (2021-11-30 to 2022-02-18)
    Posted: 2021-11-30
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  27. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 28 of 39 (2021-11-01 to 2022-02-07)
    Posted: 2021-11-16
    Subject matter details: 8
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  28. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 27 of 39 (2021-06-29 to 2021-11-01)
    Posted: 2021-06-29
    Subject matter details: 8
    Government institutions: 19
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  29. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 13 of 26 (2021-06-10 to 2021-11-30)
    Posted: 2021-06-10
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  30. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 12 of 26 (2021-05-30 to 2021-06-10)
    Posted: 2021-05-31
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  31. Abbott Laboratories Co.
    Type: Consultant
    Lobbyist: Elaine Larsen Wells, Global Public Affairs
    Registration: 1 of 1 (2021-04-15 to 2022-02-16)
    Posted: 2021-04-27
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  32. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Tracey Ramsay, Vice President and General Manager, Canada
    Registration: 26 of 39 (2021-02-01 to 2021-06-29)
    Posted: 2021-03-08
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  33. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Denis Hello, Vice President and General Manager, Canada
    Registration: 25 of 39 (2020-09-23 to 2021-02-01)
    Posted: 2020-09-24
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  34. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Denis Hello, Vice President and General Manager, Canada
    Registration: 24 of 39 (2020-09-23 to 2020-09-23)
    Posted: 2020-09-23
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  35. Abbott Laboratories
    Type: Consultant
    Lobbyist: Michael Agosti, Dentons Canada LLP
    Registration: 2 of 3 (2020-07-17 to 2022-09-01)
    Posted: 2020-08-31
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  36. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 11 of 26 (2020-06-18 to 2021-05-30)
    Posted: 2020-07-10
    Subject matter details: 3
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  37. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 10 of 26 (2020-06-12 to 2020-06-18)
    Posted: 2020-06-12
    Subject matter details: 3
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  38. Abbott Diabetes Care
    Type: Consultant
    Lobbyist: Elaine Larsen Wells, Global Public Affairs
    Registration: 1 of 1 (2020-05-25 to 2020-12-01)
    Posted: 2020-05-25
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  39. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 9 of 26 (2020-04-17 to 2020-06-12)
    Posted: 2020-04-20
    Subject matter details: 3
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  40. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 8 of 26 (2020-03-31 to 2020-04-17)
    Posted: 2020-04-07
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  41. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Denis Hello, Vice President and General Manager, Canada
    Registration: 23 of 39 (2020-03-01 to 2020-09-16)
    Posted: 2020-03-23
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  42. Abbott Diabetes Care Canada
    Type: Consultant
    Lobbyist: Jim Pimblett, Public Square Strategy
    Registration: 3 of 3 (2020-01-31 to 2020-08-16)
    Posted: 2020-02-03
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  43. Abbott Laboratories Co.
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 7 of 26 (2020-01-01 to 2020-03-31)
    Posted: 2020-01-13
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  44. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Stéphane Lassignardie, General Manager
    Registration: 22 of 39 (2019-12-17 to 2020-03-01)
    Posted: 2019-12-18
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 9
  45. Abbott Laboratories
    Type: Consultant
    Lobbyist: Michael Agosti, Dentons Canada LLP
    Registration: 1 of 3 (2019-08-19 to 2020-07-17)
    Posted: 2019-08-22
    Subject matter details: 1
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  46. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Stéphane Lassignardie, General Manager
    Registration: 21 of 39 (2019-07-16 to 2019-12-17)
    Posted: 2019-07-18
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 11
  47. Abbott Laboratories, Limited
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 6 of 26 (2019-02-06 to 2020-01-01)
    Posted: 2019-02-07
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  48. Abbott Laboratories, Limited
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 5 of 26 (2018-11-16 to 2019-02-06)
    Posted: 2018-11-22
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  49. AbbVie Corporation
    Type: In-house Corporation
    Responsible officer: Stéphane Lassignardie, General Manager
    Registration: 20 of 39 (2018-09-13 to 2019-07-16)
    Posted: 2018-09-13
    Subject matter details: 8
    Government institutions: 18
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 10
  50. Abbott Laboratories, Limited
    Type: In-house Corporation
    Responsible officer: Matthew Harris, General Manager, Abbott Nutrition Division
    Registration: 4 of 26 (2018-07-31 to 2018-11-16)
    Posted: 2018-09-11
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 1

Monthly communication reports (169)
Results: 1-50 | Export
  1. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2024-02-12
    Posted: 2024-03-15
    Designated public office holders:
    • William Messier, Quebec Advisor to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Industry
  2. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-12-19
    Posted: 2024-01-15
    Designated public office holders:
    • Helena Jaczek, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  3. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-11-09
    Posted: 2023-12-15
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister, Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Kelley Parato, Director, Human Health Therapeutics Research Centre | National Research Council (NRC)
    • Bobby Kelly, Chief of Staff | Invest in Canada Hub
    • Laurel Broten, Chief Executive Officer | Invest in Canada Hub
    Subject matters:
    • Health
    • Science and Technology
    • Industry
  4. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-10-26
    Posted: 2023-11-15
    Designated public office holders:
    • Paul Chiang, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  5. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-10-20
    Posted: 2023-11-15
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | House of Commons
    Subject matters:
    • Health
  6. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-08-31
    Posted: 2023-09-15
    Designated public office holders:
    • Stan Kutcher, Senator | Senate of Canada
    Subject matters:
    • Health
  7. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-07-27
    Posted: 2023-08-18
    Designated public office holders:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Industry
    • Health
  8. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-06-15
    Designated public office holders:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada
    Subject matters:
    • Health
  9. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-06-15
    Designated public office holders:
    • Husain Aboghodieh, Policy Advisor | Global Affairs Canada (GAC)
    Subject matters:
    • Industry
  10. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Jocelyne Voisin, ADM, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
  11. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Ed Morgan, Director General, Policy, Planning and International Affairs, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
  12. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Industry
  13. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-24
    Posted: 2023-05-15
    Designated public office holders:
    • Suki Wong, Director General, Mental Health Directorate, Strategic Policy Branch | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  14. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-04-20
    Posted: 2023-05-15
    Designated public office holders:
    • Majid Jowhari, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  15. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-03-30
    Posted: 2023-04-15
    Designated public office holders:
    • Robert Kitchen, Member of Parlilament | House of Commons
    Subject matters:
    • Health
    • Industry
  16. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-03-21
    Posted: 2023-04-15
    Designated public office holders:
    • Emelyana Titarenko, Communications and Issues Manager, Minister's Office | Health Canada (HC)
    • Jordan Ames-Sinclair, Special Assistant, Policy, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
  17. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2023-03-21
    Posted: 2023-04-15
    Designated public office holders:
    • Susan Fitzpatrick, Head, Canada Drug Agency Transition Office, Office of Pharmaceuticals Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
  18. Abbott Laboratories Co.
    Type: In-house Corporation
    Occurred: 2023-02-03
    Posted: 2023-03-15
    Designated public office holders:
    • Sarah Thomas, Policy Advisor, Office of the Deputy Prime Minister & Minister of Finance | Finance Canada (FIN)
    Subject matters:
    • Health
  19. Abbott Laboratories Co.
    Type: In-house Corporation
    Occurred: 2023-01-27
    Posted: 2023-02-15
    Designated public office holders:
    • Michael Brewster, Director, Parliamentary Affairs | Environment and Climate Change Canada (ECCC)
    Subject matters:
    • Health
  20. Abbott Laboratories Co.
    Type: In-house Corporation
    Occurred: 2022-12-15
    Posted: 2023-01-16
    Designated public office holders:
    • François-Olivier Picard, Policy advisor, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  21. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-14
    Posted: 2023-01-16
    Designated public office holders:
    • Jeff Waring, Director of Operations, Social Development Policy | Privy Council Office (PCO)
    Subject matters:
    • Health
    • Industry
  22. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-14
    Posted: 2023-01-16
    Designated public office holders:
    • Jamie Innes, Chief of Staff to the Minister | Intergovernmental Affairs Secretariat (IGA)
    Subject matters:
    • Health
    • Industry
  23. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-13
    Posted: 2023-01-16
    Designated public office holders:
    • Helen Gao, A/Chief of Staff | Indigenous Services Canada (ISC)
    Subject matters:
    • Aboriginal Affairs
    • Health
  24. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-06
    Posted: 2023-01-16
    Designated public office holders:
    • Heath MacDonald, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  25. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-06
    Posted: 2023-01-16
    Designated public office holders:
    • Robert Morrissey, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  26. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-06
    Posted: 2023-01-16
    Designated public office holders:
    • Steven MacKinnon, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  27. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-12-05
    Posted: 2023-01-16
    Designated public office holders:
    • Sameer Ahmed, Acting Consul General, Consulate General of Canada, Chicago | Global Affairs Canada (GAC)
    Subject matters:
    • Health
    • Industry
  28. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-30
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  29. Abbott Laboratories Co.
    Type: In-house Corporation
    Occurred: 2022-11-24
    Posted: 2022-12-15
    Designated public office holders:
    • Nicolas Thibodeau, Parliamentary Affairs and Policy Advisor | Senate of Canada
    Subject matters:
    • Health
  30. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-11
    Posted: 2022-12-15
    Designated public office holders:
    • Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Industry
    • Health
  31. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-10
    Posted: 2022-11-11
    Designated public office holders:
    • Shaili Patel, Director of Policy | Health Canada (HC)
    Subject matters:
    • Health
  32. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-11-07
    Posted: 2022-12-15
    Designated public office holders:
    • Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Daniel MacDonald, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Policy Division | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  33. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-03
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
  34. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-10-26
    Posted: 2022-11-03
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  35. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-10-25
    Posted: 2022-11-03
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    • Allison Haley, Director, Parliamentary Affairs, Office, Dr. Stephen Ellis | House of Commons
    Subject matters:
    • Industry
    • Health
  36. Abbott Laboratories
    Type: Consultant
    Lobbyist: Michael Agosti, Dentons Canada LLP
    Occurred: 2022-09-20
    Posted: 2022-10-15
    Designated public office holders:
    • Jill Hendren, Planning Officer, Regulatory Affairs | Environment and Climate Change Canada (ECCC)
    • Haley Maziarski, Policy Analyst, Regulatory Affairs | Environment and Climate Change Canada (ECCC)
    • shannon castellarin, Manager, Policy and Instrument Development Section (PIDS) | Environment and Climate Change Canada (ECCC)
    • Kathy Palko, Manager, Recycled Plastics, Regulatory Affairs | Environment and Climate Change Canada (ECCC)
    • Megan Hamilton, Head, Regulatory Cooperation and Implementation, Plastics Regulatory Affairs Division | Environment and Climate Change Canada (ECCC)
    • George Kendros, Physical Science Planning Officer, Regulatory Affairs | Environment and Climate Change Canada (ECCC)
    • Michael Hawco, Unit Head, Regulatory Practice | Environment and Climate Change Canada (ECCC)
    Subject matters:
    • Health
    • Environment
  37. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-09-06
    Posted: 2022-09-06
    Designated public office holders:
    • Jordan Ames-Sinclair, Special Assistant, Policy, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
  38. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-08-23
    Posted: 2022-08-23
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant (Policy and Operations) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Industry
  39. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-08-10
    Posted: 2022-08-10
    Designated public office holders:
    • Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Health
    • Industry
  40. Abbott Laboratories Co.
    Type: In-house Corporation
    Occurred: 2022-07-26
    Posted: 2022-08-15
    Designated public office holders:
    • Helen Gao, A/Chief of Staff | Indigenous Services Canada (ISC)
    Subject matters:
    • Health
  41. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-24
    Posted: 2022-06-24
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  42. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-21
    Posted: 2022-06-24
    Designated public office holders:
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  43. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-13
    Posted: 2022-06-19
    Designated public office holders:
    • Darryl Patterson, Director General, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
  44. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-06-01
    Posted: 2022-06-03
    Designated public office holders:
    • Hilary Peirce, Senior Policy Advisor, Office of the President of the Treasury Board | Treasury Board Of Canada Secretariat (TBS)
    Subject matters:
    • Industry
    • Health
  45. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-03
    Designated public office holders:
    • Jamie Kippen, Chief of Staff, Minister's Office | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  46. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-03
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  47. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-03
    Designated public office holders:
    • Ed Morgan, Director General, Policy, Planning and International Affairs Directorate | Health Canada (HC)
    Subject matters:
    • Health
  48. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-31
    Posted: 2022-06-03
    Designated public office holders:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  49. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-30
    Posted: 2022-06-03
    Designated public office holders:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  50. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-05-17
    Posted: 2022-05-19
    Designated public office holders:
    • Sandenga Yeba, Senior Policy Advisor, Minister's Office | Health Canada (HC)
    Subject matters:
    • Health
    • Industry

Date Modified: